GlassScriptPhysician profile
Charles Austin Mitchell
NPI 1063409845
$1,223.05
in general payments reported to CMS, 2019-2025
16 companies · $572 in 2025
The $572 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.70 · 2020: $31.94 · 2021: $17.56 · 2022: $86.39 · 2023: $91.14 · 2024: $400 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $950 · Education: $94.99 · Debt Forgiveness: $18.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $949.53 |
| Education | $94.99 |
| Debt Forgiveness | $18.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $231.95 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $161.97 | 2024-2025 | Dupixent, Libtayo |
| Sun Pharmaceutical Industries INC. | $151.44 | 2020-2025 | Ilumya |
| Janssen Biotech, INC. | $145.40 | 2022-2025 | Tremfya |
| Ucb, INC. | $134.00 | 2024-2025 | Bimzelx |
| Amgen INC. | $96.97 | 2025 | Otezla |
| Novartis Pharmaceuticals Corporation | $66.09 | 2023-2025 | |
| Pfizer INC. | $59.46 | 2019-2024 | |
| Incyte Corporation | $44.97 | 2024-2025 | Opzelura |
| Dermavant Sciences, INC. | $23.76 | 2024 | Vtama |
| Allergan, INC. | $23.51 | 2022 | |
| Baxter Healthcare | $18.94 | 2023 | |
| Almirall LLC | $18.13 | 2024 | Seysara |
| Organogenesis INC. | $17.49 | 2025 | Novachor |
| Strata Skin Sciences, INC. | $15.31 | 2024 | Xtrac |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $13.66 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.